Home / Resources / Test Your Knowledge / Reducing Heart Risk

Reducing Heart Risk

Feb 24, 2018

According to a recent study, which one of the following diabetes therapies carries a lower risk for adverse cardiovascular (CV) events?


Correct Answer: 3. CV risk does not differ between these agents

Explanation: Antonios Douros et al. found that the risk for adverse CV events (ie, acute myocardial infarction, ischemic stroke, CV-related death, and all-cause mortality) did not significantly differ between those who used specific, short-acting sulfonylureas vs nonspecific, long-acting agents for type 2 diabetes. However, the nonspecific, long-acting medications were linked to an increased risk for severe hypoglycemia.


Douros A, et al. Diabetes Care. 2017;40(11):1506-1513.